ClinicalTrials.govpublic full text
FMT in IT-refractory HCC - FAB-HCC Pilot Study
hepatocellular carcinoma, fecal microbiota transplant, fmt, hcc, immunotherapy, atezolizumab, bevacizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 909968
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.